Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117165) titled 'Evaluation of the Establishment and Application of a Multimodal Molecular Probe Radiomics Model for Mediastinal Lymph Node Metastasis in Lung Cancer: A Prospective Study' on Jan. 20.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: jiangxi cancer hospital
Condition:
Suspected mediastinal lymph node metastasis in non-small cell lung cancer
Intervention:
Gold Standard:Histologically confirmed
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-20
Target Sample Size: Target condition:500;Difficult condition:0
Countries of Recruitment:...